22 hrs ago
Drug firms settle with Montana for $5.9M
Montana Attorney General Tim Fox says subsidiaries of Johnson & Johnson have agreed to pay $5.9 million to settle a lawsuit with the state over the marketing of an antipsychotic drug.
Trending on the Topix Network
Wed Mar 05, 2014
Retirement Income Planning With Johnson & Johnson
For many investors approaching retirement, income planning for retirement has become extremely difficult, if not downright impossible.
Tue Mar 04, 2014
Top Brands: Most Trustworthy
Products such as Listerine, Benadryl and Band-Aid bandages are ubiquitous in consumer homes and part of daily lives.
Wed Feb 19, 2014
Defective Hip Implant Claims Center Launched by Gilman Law LLP in...
The Defective Hip Implant Claims Center at Gilman Law LLP has launched a new website to keep the public updated on important developments in the numerous litigations involving product liability lawsuits alleging serious injuries due to defective and/or recalled hip implants.
NYSE Active Stock Watch List: Johnson & Johnson (NYSE:JNJ) and Morgan ...
Equity Profile Report expands its NYSE Active Stock Weekly Watch List adding Johnson & Johnson and Morgan Stanley .
Tue Feb 18, 2014
Stryker Flexes Its Medtech Muscles
They were considered faulty and had made it to the recall list. As a consequence, the Street turned sour on Stryker's stock.
Sun Feb 16, 2014
ODU engineering grad is endowing scholarships
Toykea S. Jones graduated from ODU in 2005 and has since endowed two $25,000 scholarships at the school.
Sat Feb 15, 2014
Wall St. Cheat Sheet
Where Will Johnson & Johnson Go Next?
The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.
Fri Feb 14, 2014
FDA Rejects Wider Use Of J&J Xarelto For Third Time
Johnson & Johnson said Friday that the Food and Drug Administration has rejected - for a third time - its application to expand use of the blood thinner Xarelto to reduce dangerous blood clots and related problems in patients with coronary artery disease.
Kickbacks, Misbranding and Criminal Accusations: Johnson & Johnson...
The once-trusted healthcare products giant Johnson & Johnson entered into an agreement in November with the U.S. Department of Justice to pay one of the largest healthcare fraud settlements in U.S. history.
Tue Feb 11, 2014
The Motley Fool
3 Biotech Stocks With Great Potential in 2014
Many large health care companies experienced a challenging fourth quarter and are reporting profits down versus the prior year, but biotechnology companies Vertex Pharmaceuticals by increased research and development spending.
Fri Feb 07, 2014
Hip implant payout tops $50 million
Those who had the M2A Magnum hip implanted and replaced have until April 15 to sue Biomet Inc. in federal court if they wish to participate in the settlement.